T-Cell Lymphocytic Leukemia: Clinical Trials

1 trial for T-Cell Lymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow T-Cell Lymphocytic Leukemia: new trials by email Literature Review of T-Cell Lymphocytic Leukemia trials Research Report on T-Cell Lymphocytic Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies
Fludarabine + Cyclophosphamide + CAR7-T Cells - T-Cell Lymphocytic Leukemia, T-Cell Chronic Lymphocytic Leukemia
Phase 1UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology242021-04-152022-03-16

Narrower conditions

Leukemia, Prolymphocytic, T-Cell (1)  ·  Leukemia, T-Cell (1)  ·  Lymphoma, T-Cell (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Prolymphocytic (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (1)

Top investigators

Heng Mei (1)